← Back to Clinical Trials
Recruiting NCT05709600

NCT05709600 Dietary Interventions During Living Kidney Donations

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05709600
Status Recruiting
Phase
Sponsor University of Cologne
Condition Living-Kidney Donors
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2023-02-01
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Fasting mimicking dietKetogenic dietDietary restriction of sulfur containing amino acids

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2023-02-01 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Monocentre, non-randomized, non-blinded, open-label interventional study to identification of relevant changes in molecular biology in proteome, phosphoproteome, lipidome, epigenome and transcriptome in pretransplant kidney biopsy samples in patients preconditioned by different dietary regimes (fasting mimicking diet vs. ketogenic diet vs. dietary restriction of sulfur containing amino acids vs. control patients)

Eligibility Criteria

Inclusion Criteria: * Patients \> 18 years of age * Planed living kidney transplantation (both donor and recipient are eligible) * Written informed consent Exclusion Criteria: * Vegetarian lifestyle * Body-Mass-Index (BMI) \< 18.5 kg/m2 * Calorie-reduced diet within the preceding four weeks * Underlying wasting syndrome * Contraindication for enteral nutrition * Known allergy to or intolerance of the ingredients of the diet used * Pregnancy * Breastfeeding * Absence of safe contraceptive measures or non-occurrence of menopause (in women) * Participation in other interventional trials

Contact & Investigator

Central Contact

Felix Köhler, MD

✉ felix.koehler@uk-koeln.de

📞 +49 221 478 97222

Principal Investigator

Roman-Ulrich Müller, Prof. MD

PRINCIPAL INVESTIGATOR

Department II of Internal Medicine, University Hospital of Cologne

Frequently Asked Questions

Who can join the NCT05709600 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Living-Kidney Donors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05709600 currently recruiting?

Yes, NCT05709600 is actively recruiting participants. Contact the research team at felix.koehler@uk-koeln.de for enrollment information.

Where is the NCT05709600 trial being conducted?

This trial is being conducted at Cologne, Germany.

Who is sponsoring the NCT05709600 clinical trial?

NCT05709600 is sponsored by University of Cologne. The principal investigator is Roman-Ulrich Müller, Prof. MD at Department II of Internal Medicine, University Hospital of Cologne. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology